Hikma Pharmaceuticals Plc Company Profile (LON:HIK)

About Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc logoHikma Pharmaceuticals Plc is a pharmaceutical company. The Company develops, manufactures and markets a range of branded and non-branded generic pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms, across the United States, the Middle East and North Africa (MENA) region and Europe. The Company's segments include Branded, Injectables, Generics and Others. The Branded business sells branded generics and in-licensed products across the MENA region and other markets. The Injectables business sells specialized generic injectable products across the globe. The Generics business sells non-injectable generic products in the United States. The Branded business has approximately 380 products in over 1,120 dosage forms and strengths. Its products include Amoclan, Blopress, Omnicef, Prograf and Suprax. The Injectables business' products include Argatroban, Fentanyl, Glycopyrrolate, Nicardipine and Phenylephrine.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: HIK
  • CUSIP:
Key Metrics:
  • Previous Close: $26.94
  • 50 Day Moving Average: $2189.67
  • 200 Day Moving Average: $2244.65
  • 52-Week Range: GBX 1,575 - GBX 2,703
  • Trailing P/E Ratio: 25.23
  • P/E Growth: 0.00
  • Market Cap: $4.66B
  • Outstanding Shares: 226,000,000
Additional Links:

Analyst Ratings

Consensus Ratings for Hikma Pharmaceuticals Plc (LON:HIK) (?)
Ratings Breakdown: 3 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: GBX 2,520.90

Analysts' Ratings History for Hikma Pharmaceuticals Plc (LON:HIK)
Show:
DateFirmActionRatingPrice TargetDetails
9/23/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details
9/12/2016Jefferies GroupLower Price TargetBuyGBX 2,990 -> GBX 2,500View Rating Details
9/9/2016Barclays PLCReiterated RatingOverweightGBX 2,900View Rating Details
8/24/2016Numis Securities LtdReiterated RatingHoldGBX 2,660View Rating Details
8/12/2016Morgan StanleyLower Price TargetEqual weightGBX 2,700 -> GBX 2,500View Rating Details
8/4/2016Citigroup Inc.DowngradeNeutralGBX 2,600View Rating Details
6/24/2016Stifel NicolausReiterated RatingBuyView Rating Details
3/29/2016HSBCReiterated RatingBuyGBX 2,525View Rating Details
3/16/2016Panmure GordonUpgradeBuyGBX 2,120View Rating Details
3/10/2016AlphaValueReiterated RatingBuyGBX 2,554View Rating Details
9/15/2015Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
9/2/2015Shore CapitalUpgradeBuyView Rating Details
4/27/2015Beaufort SecuritiesReiterated RatingBuyView Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Hikma Pharmaceuticals Plc (LON:HIK)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Hikma Pharmaceuticals Plc (LON:HIK)
Current Year EPS Consensus Estimate: $1.12 EPS

Dividends

Dividend History for Hikma Pharmaceuticals Plc (LON:HIK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/11/2015GBX 0.210.64%4/16/20154/16/20155/21/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Hikma Pharmaceuticals Plc (LON:HIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/23/2016Ali Al-HusryInsiderBuy50,000GBX 2,099£1,049,500
9/21/2016Ali Al-HusryInsiderBuy50,000GBX 2,138£1,069,000
9/16/2016Al-Husry,AliInsiderBuy50,000GBX 2,119£1,059,500
9/15/2016Darwazah,SaidInsiderBuy70,251GBX 2,122£1,490,726.22
9/8/2016Darwazah,MazenInsiderBuy150,000GBX 2,162£3,243,000
9/6/2016Darwazah,MazenInsiderBuy155,991GBX 2,194£3,422,442.54
8/31/2016Al-Husry,AliInsiderBuy140,000GBX 2,150£3,010,000
8/26/2016Darwazah,SaidInsiderBuy200,000GBX 2,160£4,320,000
6/24/2016Darwazah,MazenInsiderBuy150,000GBX 2,200£3,300,000
6/17/2016Al-Husry,AliInsiderBuy70,000GBX 22£15,400
5/9/2016Darwazah,SaidInsiderBuy17,440GBX 2,228£388,563.20
4/26/2016Darwazah,SaidInsiderBuy10,000GBX 2,260£226,000
4/25/2016Darwazah,SaidInsiderBuy10,000GBX 2,324£232,400
4/22/2016Darwazah,SaidInsiderBuy30,000GBX 2,325£697,500
4/20/2016Darwazah,SaidInsiderBuy30,000GBX 2,271£681,300
4/19/2016Darwazah,SaidInsiderBuy30,000GBX 2,266£679,800
4/11/2016J. Castellani,JohnInsiderBuy2,500GBX 2,103£52,575
4/7/2016Darwazah,MazenInsiderBuy60,000GBX 2,118£1,270,800
4/5/2016Darwazah,SaidInsiderBuy30,000GBX 2,055£616,500
3/31/2016Darwazah,SaidInsiderBuy30,000GBX 1,972£591,600
3/24/2016Butler,PatInsiderBuy2,500GBX 1,920£48,000
3/21/2016Pickering ,RobertInsiderBuy2,500GBX 1,856£46,400
8/27/2015Kirby,PamelaInsiderBuy3,317GBX 2,264£75,096.88
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Hikma Pharmaceuticals Plc (LON:HIK)
DateHeadline
News IconGlobal Nerve Gas Auto-Injector Market Research Report 2016: MERIDIAN MEDICAL TECHNOLOGIES., SIGMA-ALDRICH CO. LLC., SOPHARMA AD (LON:HIK)
www.medgadget.com - September 23 at 5:05 PM
4-traders.com logoHikma Pharmaceuticals : Board appointment and succession (LON:HIK)
www.4-traders.com - September 20 at 10:34 AM
rttnews.com logoHikma Pharma Announces Changes To Board Composition (LON:HIK)
www.rttnews.com - September 20 at 10:34 AM
publicnow.com logoBoard appointment and succession (LON:HIK)
www.publicnow.com - September 20 at 10:34 AM
uk.finance.yahoo.com logoShould you buy GlaxoSmithKline plc after its change in CEO? (LON:HIK)
uk.finance.yahoo.com - September 20 at 10:34 AM
News IconHikma Pharmaceuticals Plc (HIK) Price Target Cut to GBX 2500 by Analysts at Jefferies Group - NewsDen (LON:HIK)
newsden.net - September 18 at 5:10 PM
4-traders.com logoDIRECTOR DEALINGS: Hikma Directors Up Stake As Darhold Acquires Shares (LON:HIK)
www.4-traders.com - September 15 at 5:47 PM
directorstalkinterviews.com logoHikma Pharmaceuticals Plc 17% Potential Upside Indicated by JP Morgan Cazenove - DirectorsTalk Interviews (LON:HIK)
www.directorstalkinterviews.com - September 14 at 5:33 PM
trustnet.com logoBroker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC (LON:HIK)
www.trustnet.com - September 14 at 9:40 AM
News IconXL Group PLC (XL) Downgraded by Janney Montgomery Scott (LON:HIK)
magseriesusa.net - September 12 at 5:20 PM
morningstar.co.uk logoDIRECTOR DEALINGS: Hikma Directors Up Stake As Darhold Buys Shares (LON:HIK)
www.morningstar.co.uk - September 8 at 5:21 PM
publicnow.com logoHikma Ventures invests in Chrono Therapeutics for the development of next generation transdermal drug delivery technology (LON:HIK)
www.publicnow.com - September 8 at 9:21 AM
bloomberg.com logoU.K. Stocks Jump Most Since June, Reversing Three-Day Decline (LON:HIK)
washpost.bloomberg.com - September 2 at 5:23 PM
marketwatch.com logoFTSE 100 rallies as weak U.S. jobs data seen delaying rate hike (LON:HIK)
www.marketwatch.com - September 2 at 10:16 AM
capitalcube.com logoETF’s with exposure to Hikma Pharmaceuticals Plc : September 2, 2016 (LON:HIK)
www.capitalcube.com - September 2 at 10:16 AM
4-traders.com logoDIRECTOR DEALINGS: Hikma Non-Executive Director Buys Shares (LON:HIK)
www.4-traders.com - August 26 at 5:16 PM
News IconIs It The Right Time To Buy Hikma Pharmaceuticals Plc (LON:HIK) Shares? - Simply Wall St (LON:HIK)
simplywall.st - August 26 at 8:25 AM
fool.co.uk logoIs Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today's update? - Motley Fool UK (LON:HIK)
www.fool.co.uk - August 26 at 8:25 AM
marketwatch.com logoHikma profit falls 14%; sticks to revenue forecast (LON:HIK)
www.marketwatch.com - August 25 at 10:26 AM
bloomberg.com logoDrugmakers, Miners Send British Stocks Toward Three-Week Low (LON:HIK)
washpost.bloomberg.com - August 25 at 10:26 AM
4-traders.com logoHikma Pharmaceuticals' : H1 posts drop 38% YoY (LON:HIK)
www.4-traders.com - August 25 at 10:26 AM
money.aol.co.uk logoIs Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today's update? - AOL Money UK (LON:HIK)
money.aol.co.uk - August 24 at 8:32 AM
biz.yahoo.com logoHalf Year 2016 Hikma Pharmaceuticals PLC Earnings Release - Before Market Open (LON:HIK)
biz.yahoo.com - August 24 at 8:32 AM
feeds.reuters.com logoDrugmaker Hikma first-half core operating profit falls 14 pct (LON:HIK)
feeds.reuters.com - August 24 at 3:18 AM
proactiveinvestors.co.uk logoFTSE 100 up 27 points (LON:HIK)
www.proactiveinvestors.co.uk - August 23 at 5:36 PM
proactiveinvestors.co.uk logoFTSE 100 pushes higher as supermarkets rally (LON:HIK)
www.proactiveinvestors.co.uk - August 23 at 9:48 AM
capitalcube.com logoETF’s with exposure to Hikma Pharmaceuticals Plc : August 18, 2016 (LON:HIK)
www.capitalcube.com - August 19 at 8:21 AM
capitalcube.com logoHikma Pharmaceuticals Plc :HIK-GB: Earnings Analysis: For the six months ended December 31, 2015 : August 17, 2016 (LON:HIK)
www.capitalcube.com - August 17 at 8:30 AM
publicnow.com logoHikma signs exclusive licensing, distribution and supply agreement with Basilea Pharmaceutica International Ltd. for Cresemba® (LON:HIK)
www.publicnow.com - August 17 at 8:30 AM
publicnow.com logoHikma announces the launch of Levoleucovorin for Injection in the US (LON:HIK)
www.publicnow.com - August 16 at 5:37 PM
News IconUS and EU Requirements for Pre-Merger Notification of an Acquisition of a Minority Shareholding Interest (LON:HIK)
www.natlawreview.com - August 10 at 12:50 PM
ftsenews.co.uk logoBarclays Capital reiterated Hikma Pharmaceuticals PLC (LON:HIK) as 'Overweight' With 2900 PT - FTSE News (LON:HIK)
www.ftsenews.co.uk - August 9 at 8:23 AM
4-traders.com logoHikma Pharmaceuticals : *BARCLAYS RAISES HIKMA PHARMACEUTICAL PT TO 2900 PENCE - 'OVERWEIGHT' (LON:HIK)
www.4-traders.com - August 8 at 5:37 PM
capitalcube.com logoETF’s with exposure to Hikma Pharmaceuticals Plc : August 8, 2016 (LON:HIK)
www.capitalcube.com - August 8 at 5:37 PM
directorstalkinterviews.com logoHikma Pharmaceuticals Plc 20.1% Potential Upside Indicated by Barclays Capital - DirectorsTalk Interviews (LON:HIK)
www.directorstalkinterviews.com - August 8 at 10:09 AM
ft.com logo[$$] AstraZeneca climbs to a record high (LON:HIK)
ad.doubleclick.net - August 8 at 10:09 AM
ftsenews.co.uk logoBarclays Capital Gives Hikma Pharmaceuticals PLC Price Target With Potential 4.95% Upside - FTSE News (LON:HIK)
www.ftsenews.co.uk - August 6 at 8:18 AM
ftsenews.co.uk logoJefferies International Reiterated Hikma Pharmaceuticals PLC (LON:HIK) As 'Buy' - FTSE News (LON:HIK)
www.ftsenews.co.uk - August 5 at 5:34 PM
News IconAviva, Hikma Pharma, Hannover, Inmarsat, Siemens, Societe BIC Net Decline - 123Jump.com (LON:HIK)
www.123jump.com - August 5 at 8:21 AM
ftsenews.co.uk logoNumis Gives Hikma Pharmaceuticals PLC Price Target With Potential 16.67% Upside - FTSE News (LON:HIK)
www.ftsenews.co.uk - August 5 at 8:21 AM
capitalcube.com logoHikma Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : HIK-GB : August 5, 2016 (LON:HIK)
www.capitalcube.com - August 5 at 8:21 AM
bloomberg.com logoU.K. Equities Rally Most Since June After BOE Boosts Stimulus (LON:HIK)
washpost.bloomberg.com - August 4 at 5:44 PM
News IconHikma Pharmaceuticals: Trading update (LON:HIK)
www.pharmiweb.com - August 4 at 5:44 PM
News IconAviva, Hikma Pharma, Hannover, Inmarsat, Siemens, Societe BIC Net Decline (LON:HIK)
www.123jump.com - August 4 at 5:44 PM
marketwatch.com logoHikma cuts profit target on generics unit (LON:HIK)
www.marketwatch.com - August 4 at 5:44 PM
bloomberg.com logoU.K. Stocks Rise in Broad-Based Rally After BOE Boosts Stimulus - Bloomberg (LON:HIK)
www.bloomberg.com - August 4 at 8:24 AM
sg.finance.yahoo.com logoFTSE rallies after BoE decision, Hikma sinks (LON:HIK)
sg.finance.yahoo.com - August 4 at 8:24 AM
morningstar.co.uk logoTOP NEWS: Hikma Expects Hit To Full Year Generics Profitability (LON:HIK)
www.morningstar.co.uk - August 3 at 5:44 PM
reuters.com logoBRIEF-Hikma sees FY revenue between $2-$2.1 bln (LON:HIK)
www.reuters.com - August 3 at 5:44 PM
sg.finance.yahoo.com logoHikma says generic drug unit to be hit by approval delays (LON:HIK)
sg.finance.yahoo.com - August 3 at 5:44 PM

Social


Last Updated on 9/28/2016 by MarketBeat.com Staff